Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
426.20 SEK | +1.09% | +4.76% | +6.86% |
07:16am | Odin Sweden increased 0.68 percent in December - added Mycronic and EQT to the portfolio | FW |
Jan. 14 | Moderate rise on the Stockholm Stock Exchange, OMXS30 index up 0.3 percent | FW |
Capitalization | 41.14B 3.69B 3.58B 3.37B 3.01B 5.29B 319B 5.93B 15.26B 131B 13.84B 13.55B 578B | P/E ratio 2024 * |
27.1x | P/E ratio 2025 * | 26.7x |
---|---|---|---|---|---|
Enterprise value | 38.07B 3.41B 3.32B 3.12B 2.79B 4.89B 295B 5.49B 14.12B 121B 12.81B 12.54B 535B | EV / Sales 2024 * |
5.67x | EV / Sales 2025 * | 5.01x |
Free-Float |
76.8% | Yield 2024 * |
1.16% | Yield 2025 * | 1.45% |
Last Transcript: Mycronic AB
1 day | +1.09% | ||
1 week | +4.76% | ||
Current month | +6.86% | ||
1 month | +4.81% | ||
3 months | +13.93% | ||
6 months | +2.94% | ||
Current year | +6.86% |
Director | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 58 | 2019-05-15 | |
Pierre Brorsson
DFI | Director of Finance/CFO | 52 | 2021-10-24 |
Chief Tech/Sci/R&D Officer | 57 | 2003-12-31 |
Manager | Title | Age | Since |
---|---|---|---|
Director/Board Member | 67 | 2010-03-31 | |
Chairman | 61 | 2011-12-31 | |
Anna Belfrage
BRD | Director/Board Member | 63 | 2018-05-07 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.01% | 0 M€ | -3.35% | - | |
0.00% | 54 M€ | +0.63% | - |
Change | 5d. change | 1-year change | 3-years change | Capi. ($) | ||
---|---|---|---|---|---|---|
+1.09% | +4.76% | +52.97% | +115.56% | 3.69B | ||
+2.93% | -0.05% | +12.45% | +11.78% | 288B | ||
+4.05% | +5.83% | +3.80% | +16.35% | 97.98B | ||
+3.88% | -3.23% | +1.54% | +22.59% | 75.16B | ||
+2.17% | -3.79% | +31.47% | +56.40% | 21.26B | ||
+1.95% | +4.89% | -7.96% | -18.61% | 15.39B | ||
+2.93% | +10.75% | +42.33% | +123.36% | 10.11B | ||
+1.62% | -0.23% | -16.60% | +9.76% | 6.23B | ||
+5.48% | +1.97% | -16.78% | +62.97% | 5.6B | ||
+2.39% | +4.94% | -22.45% | -50.43% | 5.29B | ||
Average | +2.85% | -0.05% | +8.08% | +34.97% | 52.89B | |
Weighted average by Cap. | +3.21% | -1.94% | +9.32% | +17.82% |
2024 * | 2025 * | |
---|---|---|
Net sales | 6.71B 602M 585M 550M 492M 863M 52.01B 968M 2.49B 21.35B 2.26B 2.21B 94.28B | 7.35B 659M 641M 602M 539M 945M 56.95B 1.06B 2.73B 23.37B 2.47B 2.42B 103B |
Net income | 1.53B 137M 133M 125M 112M 196M 11.82B 220M 566M 4.85B 513M 502M 21.42B | 1.55B 139M 135M 127M 113M 199M 11.98B 223M 574M 4.92B 520M 509M 21.72B |
Net Debt | -3.08B -276M -268M -252M -226M -396M -23.84B -444M -1.14B -9.79B -1.04B -1.01B -43.22B | -4.31B -386M -375M -353M -316M -554M -33.37B -621M -1.6B -13.7B -1.45B -1.42B -60.5B |
Date | Price | Change | Volume |
---|---|---|---|
25-01-16 | 426.80 kr | +1.23% | 40,852 |
25-01-15 | 421.60 kr | +3.18% | 78,642 |
25-01-14 | 408.60 kr | +4.13% | 233,843 |
25-01-13 | 392.40 kr | -1.60% | 157,739 |
25-01-10 | 398.80 kr | -2.11% | 80,308 |
Delayed Quote Nasdaq Stockholm, January 16, 2025 at 09:46 am EST
More quotesQuarterly revenue - Rate of surprise
- Stock Market
- Equities
- MYCR Stock